Dialysis vascular accesses called arteriovenous fistulas ( AVF) are essential to ensure extra-renal purification by hemodialysis for patients with chronic end-stage renal disease. Complications of dialysis AVF cause significant morbidity and hospitalization. Dialysis AVF angioplasties are frequently used to treat stenosis, the 1st complication concerning them and which announces the complete thrombosis which may be the definitive loss of the AVF. Historically performed under X-ray, the progression in the quality of ultrasound scanners allows today to perform this procedure under echo-Doppler guidance and thus to avoid both radiation and the injection of iodinated contrast products and their complications. It is thus possible to preserve residual renal function, a situation with a better prognosis, or to help the maturation of the AVF without precipitating the patient towards dialysis. The procedure can then be less costly, requiring a much lighter infrastructure. The complication rates of ultrasound angioplasty remain poorly known because only a few series have been published. In addition, the evolution of the echo-Doppler parameters of the AVF is unknown during angioplasty and it is difficult to know which are the most reliable to distinguish during the procedure a "good angioplasty gesture" from an incomplete angioplasty to be continued. The proposed study would provide initial insight into the question posed.
This is an observational, retrospective study on data from routine care. All angioplasties concerning major patients, meeting the inclusion criteria and performed during the inclusion period will be taken into account. (For this purpose, a list of procedures performed at the Vichy Hospital will be established via the angioplasty procedure reports. In order to establish the evolution of the echographic parameters over time, the echographic data will also be collected from each follow-up report corresponding to each procedure until the end of the follow-up. These reports correspond to the normal post-intervention control ultrasounds at 1 month, 3 months and the annual visits. If intermediate ultrasounds are available, their reports will also be used. In the case of a patient having an emergency angioplasty, the data of the control ultrasound triggering the intervention will be used as pre-intervention data.
Study Type
OBSERVATIONAL
Enrollment
144
Transluminal angioplastie
Centre Hospitalier de Vichy (CHV)
Vichy, France
morbidity and mortality
The primary outcome measure to evaluate morbidity and mortality will be the number of acute complications that occurred during the procedure and by type of complication (wall hematoma, thrombosis, rupture, spasm, injection site hematoma, pseudoaneurysm, failure)
Time frame: during intervention
Post-angioplasty permeability
Post-angioplasty primary permeability, and post-angioplasty primary assisted permeability and post-angioplasty secondary permeability over the entire follow-up period
Time frame: 2 years
Stenosis diameter
Variation of the stenosis diameter
Time frame: pre-intervention, immediately after the intervention, 1 month
Endoluminal reference diameter
Variation of the endoluminal diameter
Time frame: pre-intervention, immediately after the intervention, 1 month
Maximum systolic velocity (VSmax)
Variation of the maximum systolic velocity
Time frame: pre-intervention, immediately after the intervention, 1 month
Ratio of VSmax to upstream
Varation of Ratio of VSmax to upstream
Time frame: pre-intervention, immediately after the intervention, 1 month
End-diastolic velocity
Variation of end-diastolic velocity
Time frame: pre-intervention, immediately after the intervention, 1 month
Diameter of the anastomosis
Variation of anastomosis diameter
Time frame: pre-intervention, immediately after the intervention, 1 month
Brachial artery Maximum flow
Variation of brachial artery maximum flow
Time frame: pre-intervention, immediately after the intervention, 1 month
Brachial artery end-diastolic velocity (EDV)
Varaition of Brachial artery end-diastolic velocity
Time frame: pre-intervention, immediately after the intervention, 1 month
Brachial artery maximum systolic velocity
Variation of brachial artery maximum systolic velocity
Time frame: pre-intervention, immediately after the intervention, 1 month
Brachial artery Resistance Index
Variation of brachial artery Resistance Index
Time frame: pre-intervention, immediately after the intervention, 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.